相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized Trial of Hypofractionated External-Beam Radiotherapy for Prostate Cancer
Alan Pollack et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Hypofractionation for Clinically Localized Prostate Cancer
Alvin R. Cabrera et al.
SEMINARS IN RADIATION ONCOLOGY (2013)
HYPOFRACTIONATED CONCOMITANT INTENSITY-MODULATED RADIOTHERAPY BOOST FOR HIGH-RISK PROSTATE CANCER: LATE TOXICITY
Harvey Quon et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Updated Results and Patterns of Failure in a Randomized Hypofractionation Trial for High-risk Prostate Cancer
Stefano Arcangeli et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Improved Clinical Outcomes With High-Dose Image Guided Radiotherapy Compared With Non-IGRT for the Treatment of Clinically Localized Prostate Cancer
Michael J. Zelefsky et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
PELVIC NODAL RADIOTHERAPY IN PATIENTS WITH UNFAVORABLE INTERMEDIATE AND HIGH-RISK PROSTATE CANCER: EVIDENCE, RATIONALE, AND FUTURE DIRECTIONS
Lisa K. Morikawa et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
A PROSPECTIVE PHASE III RANDOMIZED TRIAL OF HYPOFRACTIONATION VERSUS CONVENTIONAL FRACTIONATION IN PATIENTS WITH HIGH-RISK PROSTATE CANCER
Giorgio Arcangeli et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
TOXICITY ASSESSMENT OF PELVIC INTENSITY-MODULATED RADIOTHERAPY WITH HYPOFRACTIONATED SIMULTANEOUS INTEGRATED BOOST TO PROSTATE FOR INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER
Robert McCammon et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer
Valerie Fonteyne et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Acute toxicity of whole-pelvis IMRT in 87 patients with localized prostate cancer
Giuseppe Sanguineti et al.
ACTA ONCOLOGICA (2008)
Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer
Michael J. Zelefsky et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer despite two negative randomized trials
Paul L. Nguyen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: Updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions
Colleen A. Lawton et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience
Patrick A. Kupelian et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Chronic genitourinary and gastrointestinal toxicity of prostate cancer patients undergoing pelvic radiotherapy with intensity-modulated versus 4-field technique
Andy W. Su et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2007)
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
Mack Roach et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
The radiobiology of prostate cancer including new aspects of fractionatedradiotherapy
JF Fowler
ACTA ONCOLOGICA (2005)
How low is the α/β ratio for prostate cancer?
HB Kal et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules
JF Fowler et al.
RADIOTHERAPY AND ONCOLOGY (2003)
What hypofractionated protocols should be tested for prostate cancer?
JF Fowler et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation therapy oncology group 9413
M Roach et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients
MJ Zelefsky et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
M Bolla et al.
LANCET (2002)
Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate
CA Lawton et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
分享论文
